Company · CIK 0001435049
CHINOOK THERAPEUTICS, INC.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/ACHINOOK THERAPEUTICS, INC.0001104659-23-120754 · 74.5 KBSEC(opens sec.gov)
- SC 13DCHINOOK THERAPEUTICS, INC.0000908834-23-000097 · 1.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-210803 · 245.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-23-039041 · 13.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-202849 · 149.3 KBSEC(opens sec.gov)
- SC 13G/ACHINOOK THERAPEUTICS, INC.0001088875-23-000101 · 10.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-196908 · 191.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-169726 · 213.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-167916 · 163.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-165337 · 489.4 KBSEC(opens sec.gov)
Insiders
- AKKARAJU SRINIVASDirector
- Azelby RobertDirector
- BJERKHOLT ERICChief Financial Officer
- Brockstedt Dirk G.EVP of Research and Dev.
- Chan GeraldDirector
- DOBMEIER ERICDirector, President, CEO
- Dubensky Thomas W.Chief Scientific Officer
- Ferber CelesteSVP, GC and Secretary
- Frohlich TomChief Operating Officer
- Glicklich AlanChief Medical Officer
Tickers
No tickers on record.
Addresses
business
400 FAIRVIEW AVENUE NORTH, SUITE 900
SEATTLE, WA, 98109
mailing
400 FAIRVIEW AVENUE NORTH, SUITE 900
SEATTLE, WA, 98109
Former names
- ADURO BIOTECH, INC.2020-10-15
- ADURO BIOTECH2011-04-22
Same industry